- 著者
- Rubuna Sato Masahiro Ishikane Noriko Kinoshita Tetsuya Suzuki Takato Nakamoto Kayoko Hayakawa Norifumi Bekki Hisao Hara Norio Ohmagari
- 出版者
- National Center for Global Health and Medicine
- 雑誌
- Global Health & Medicine (ISSN:24349186)
- 巻号頁・発行日
- pp.2020.01044, (Released:2020-05-15)
- 参考文献数
- 13
- 被引用文献数
- 13
Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate to severe COVID-19 cases in Japan, and report a case of COVID-19 pneumonia with anticoagulation treatment. Although several promising drugs for COVID-19 are being tested in clinical trials, definitive treatments have not yet been established. In this report, we demaonstrate that anticoagulation treatment with unfractionated heparin has the possibility of becoming at least a supportive treatment for COVID-19 patients.
言及状況
外部データベース (DOI)
Twitter (6 users, 8 posts, 1 favorites)
A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan https://t.co/a72M2SClYj
COVID-19において凝固亢進により肺塞栓症や深部静脈血栓症を生じる症例が報告され、抗凝固療法により致命率が低下する可能性も示されている。COVID-19に
あ、この中に「抗凝固療法として」ですが、生ヘパリン(UFH)を入れる提案("アルゴリズム"有り)をしてる論文がありました。
重症者に用いて挿管を回避できた事例もあったそうです。
https://t.co/B9PmzQoaaL https://t.co/hMfwxfxZAm https://t.co/SZdnm649SJ
Global Health & Medicine誌から COVID-19患者への抗凝固療法アルゴリズム：日経メディカル https://t.co/mEdCy2erzy
国立国際医療研究センターが日本人患者向けの提案
https://t.co/4hPpvxAXEq
J-STAGE Articles - A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan https://t.co/0vFDYcUZH2
Hypercoagulation and anticoagulation treatment have become new challenges in coronavirus disease 2019 (COVID-19) patients during the COVID-19 pandemic. We herein suggest an algorithm for an anticoagulation treatment with unfractionated heparin in moderate https://t.co/E0g48YNyvf